Orton Jackson Endowed Chair in Adolescent Medicine
The Children's Hospital of Philadelphia
Perelman School of Medicine
University of Pennsylvania
The educational design of this activity addresses the needs of OB/GYN MDs, NPs, PAs, and nurse specialists—as well as fellows, residents, residency directors, and physician educators.
Upon completion of this program, participants will be better able to:
- Demonstrate an understanding of HIV epidemiology among women in the United States
- Incorporate HIV risk and PrEP eligibility assessment for all sexually active patients in the OB/GYN setting
- Describe key components of PrEP initiation and management for the OB/GYN patient population
This Interactive Professor™ session is designed to educate obstetricians and gynecologists in assessing patients for risk of HIV acquisition, and in selecting, initiating, and conducting ongoing monitoring of preexposure prophylaxis (PrEP) regimens to prevent HIV.
- HIV burden among women in the United States
- Discussing sexual health without stigma or judgment
- What is PrEP?
- Selecting, initiating, and monitoring PrEP regimens
Physician Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Continuing Eduction
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and Integritas Communications. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 0.50 contact hours (which includes 0.1 hour of pharmacology).
Instructions to Receive Credit
To receive credit for this activity, participants must successfully pass the posttest with a score of 70% and complete the evaluation.
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosures of Relevant Financial Relationships
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
Renata Sanders, MD, MPH, ScM has nothing to disclose.
The planners and managers at Global Education Group and Integritas Communications have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Integritas Communications do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Global Contact Information
For information about the approval of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org.